Overview Post Marketing Surveillance Study To Observe Safety And Efficacy Of Sutene Status: Completed Trial end date: 2015-03-01 Target enrollment: Participant gender: Summary To monitor use in real practice including adverse events and efficacy on Sutent capsules (Sunitinib malate) Details Lead Sponsor: PfizerTreatments: Sunitinib